Advertisement
Advertisement
U.S. Markets closed
Advertisement
Advertisement
Advertisement
Advertisement

InVivo Therapeutics Holdings Corp. (NVIV)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
4.5400-0.1000 (-2.16%)
At close: 04:00PM EDT
4.2700 -0.27 (-5.95%)
After hours: 05:46PM EDT
Advertisement
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Previous Close4.6400
Open4.4729
Bid4.4400 x 1000
Ask4.5300 x 900
Day's Range4.4900 - 4.5600
52 Week Range3.5000 - 23.2500
Volume3,682
Avg. Volume20,714
Market Cap155.562M
Beta (5Y Monthly)N/A
PE Ratio (TTM)N/A
EPS (TTM)-0.3180
Earnings DateAug 11, 2020 - Aug 17, 2020
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
  • Benzinga

    Why Are InVivo Therapeutics Shares Trading Lower During Premarket Monday?

    InVivo Therapeutics Holdings Corp (NASDAQ: NVIV) has announced a 1-for-25 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. InVivo Therapeutics is a research and clinical-stage biomaterials and biotechnology company focusing on treating spinal cord injuries. The company anticipates the reverse stock split will become effective and start trading on a post-split basis on April 27. Every 25 shares of InVivo Therapeutics common stock will be combin

  • MarketWatch

    InVivo Therapeutics stock sinks after 1-for-25 reverse stock split announced

    InVivo Therapeutics Holdings Corp. said Thursday it will carry out a 1-for-25 reverse stock split, which is intended to increase the per-share trading price of its stock and fulfill the Nasdaq Capital Market's $1 minimum bid price requirement.

  • Business Wire

    InVivo Therapeutics Announces Reverse Stock Split

    CAMBRIDGE, Mass., April 14, 2022--InVivo Therapeutics Holdings Corp. (Nasdaq: NVIV) today announced a 1-for-25 reverse stock split of its common stock and a proportionate reduction in its authorized common stock. The company anticipates the reverse stock split will become effective at 5:00 p.m. Eastern Time on April 26, 2022, and shares of InVivo Therapeutics common stock will trade on a post-split basis under the company's existing trading symbol, "NVIV," at the market open on April 27, 2022. T

Advertisement
Advertisement